Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Peoria, Arizona 85381


Purpose:

To evaluate the safety, tolerability, and efficacy of milnacipran when taken with another drug called pregabalin in people with fibromyalgia.


Criteria:

Inclusion Criteria: - diagnosis of fibromyalgia defined by 1990 American College of Rheumatology (ACR) Criteria - tolerate at least 300 mg/day of pregabalin - have an incomplete response to pregabalin treatment Exclusion Criteria: - suicidal risk - substance abuse - pulmonary dysfunction - renal impairment - active cardiac disease - liver disease - narrow angle glaucoma - autoimmune disease - cancer - inflammatory bowel disease - unstable endocrine disease - prostatic enlargement


NCT ID:

NCT00797797


Primary Contact:

Study Director
Patricia D'Astoli
Forest Research Institute, a subsidiary of Forest Laboratories, Inc.


Backup Contact:

N/A


Location Contact:

Peoria, Arizona 85381
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.